On June 27, 2025, Moleculin Biotech, Inc. received a warning from Nasdaq due to its stock price being below $1.00 for 30 consecutive days; it has until December 24, 2025, to meet the requirement again. If it fails to do so, it may face delisting, but it can appeal the decision.